Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$628M |
| 2 |
Boston Scientific
BSX
|
+$399M |
| 3 |
Eli Lilly
LLY
|
+$366M |
| 4 |
Apple
AAPL
|
+$304M |
| 5 |
Shopify
SHOP
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$741M |
| 2 |
Meta Platforms (Facebook)
META
|
+$537M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$487M |
| 4 |
American Tower
AMT
|
+$449M |
| 5 |
Workday
WDAY
|
+$353M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Consumer Discretionary | 17.94% |
| 3 | Healthcare | 14.26% |
| 4 | Communication Services | 12.28% |
| 5 | Financials | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Fate Therapeutics
FATE
$293M
| $25.6M | 0.03% |
1,307,006
+7,638
| +0.6% | +$121K |
|
277
Philip Morris
PM
$299B
| $25.6M | 0.03% |
300,574
-54,413
| -15% | -$4.48M |
|
|
SWAV
278
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $25.5M | 0.03% |
580,334
+276,907
| +91% | +$10.2M |
|
279
Monro
MNRO
$421M
| $25.5M | 0.03% |
325,743
-5,467
| -2% | -$412K |
|
280
Diamondback Energy
FANG
$56.2B
| $25.3M | 0.03% |
272,227
-68,800
| -20% | -$5.71M |
|
281
Madrigal Pharmaceuticals
MDGL
$11.4B
| $25.2M | 0.03% |
276,430
+741
| +0.3% | +$71.9K |
|
282
Lazard
LAZ
$4.09B
| $24.9M | 0.03% |
623,081
-104,466
| -14% | -$3.95M |
|
|
PINC
283
DELISTED
Premier
PINC
| $24.9M | 0.03% |
656,768
-3,842
| -0.6% | -$135K |
|
284
Q2 Holdings
QTWO
$3.68B
| $24.8M | 0.03% |
306,399
-94,775
| -24% | -$7.28M |
|
|
AMTD
285
DELISTED
TD Ameritrade Holding Corp
AMTD
| $24.7M | 0.02% |
497,463
-380,689
| -43% | -$16.5M |
|
286
Cheniere Energy
CQP
$31.5B
| $24.4M | 0.02% |
613,782
-5,208
| -0.8% | -$219K |
|
287
Vulcan Materials
VMC
$35.1B
| $24.4M | 0.02% |
169,337
-124,243
| -42% | -$17.8M |
|
288
Dow Inc
DOW
$21.7B
| $24.3M | 0.02% |
+443,909
| New | +$22.9M |
|
289
nLIGHT
LASR
$3.71B
| $23.5M | 0.02% |
1,157,082
+63,824
| +6% | +$1.1M |
|
290
Stanley Black & Decker
SWK
$14.4B
| $23M | 0.02% |
+138,962
| New | +$21.5M |
|
291
MaxLinear
MXL
$6.07B
| $22.1M | 0.02% |
1,040,914
-253,359
| -20% | -$5.26M |
|
292
US Foods
USFD
$22.1B
| $22M | 0.02% |
525,983
-138,870
| -21% | -$5.57M |
|
293
TSMC
TSM
$2.09T
| $21.9M | 0.02% |
377,335
+371,798
| +6,715% | +$19.7M |
|
294
Byline Bancorp
BY
$1.78B
| $21.9M | 0.02% |
1,118,339
-628,107
| -36% | -$11.5M |
|
295
MPLX
MPLX
$58.5B
| $21.9M | 0.02% |
859,631
-9,781
| -1% | -$249K |
|
296
TC Energy
TRP
$70.9B
| $21.8M | 0.02% |
409,955
+7,012
| +2% | +$360K |
|
297
Etsy
ETSY
$7.89B
| $21.8M | 0.02% |
491,795
-419,774
| -46% | -$20M |
|
298
Renasant Corp
RNST
$3.96B
| $21.6M | 0.02% |
610,760
-8,867
| -1% | -$313K |
|
|
PE
299
DELISTED
PARSLEY ENERGY INC
PE
| $21.3M | 0.02% |
1,125,160
+383,437
| +52% | +$6.33M |
|
300
MGP Ingredients
MGPI
$380M
| $21.2M | 0.02% |
438,384
+71,592
| +20% | +$3.35M |
|
Similar funds
Jennison Associates's Q4 2019 Portfolio in Review
As of Q4 2019, Jennison Associates held 706 positions worth $99.1B, up 4.7% from $94.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jennison Associates withdrew a net $6.18B in Q4 2019, closing 88 positions and reducing 342 holdings. Its most notable exit was Hexcel, an estimated $85.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in RingCentral worth $117M.
- Jennison Associates's largest Q4 2019 buy was RingCentral: 694,616 shares worth $117M.
- Jennison Associates added most to Coupa Software Incorporated in Q4 2019, an estimated $628M increase.
- Jennison Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $741M.
- Jennison Associates fully exited Hexcel in Q4 2019, selling an estimated $85.1M.
- Jennison Associates's ten largest holdings make up 34% of its $99.1B portfolio in Q4 2019.
- Jennison Associates opened 70 new positions and closed 88 in Q4 2019.
- Jennison Associates's portfolio value rose 4.7% quarter-over-quarter to $99.1B.
Based on Jennison Associates's 13F filing for Q4 2019, filed 7 Feb 2020.